LUNG
Pulmonx Corporation
NASDAQHealthcareMedical - DevicesUS
Rating:C-
Company Profile
CEO
Glendon E. French
IPO Date
2020-10-01
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Pulmonx Corporation
CEO
Glendon E. French
IPO Date
2020-10-01
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
| 40,000 |
| $0.00 |
| 9 Jun 2026 | Florin Daniel P | director | A-Award | Acquired | 40,000 | $0.00 |
| 9 Jun 2026 | Melenikiotou Georgia | director | A-Award | Acquired | 40,000 | $0.00 |
| 9 Jun 2026 | Sullivan Tiffany | director | A-Award | Acquired | 40,000 | $0.00 |
| 9 Jun 2026 | Mead Dana G Jr. | director | A-Award | Acquired | 40,000 | $0.00 |
| 4 Mar 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | S-Sale | Disposed | 3,068 | $1.43 |
| 4 Mar 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | S-Sale | Disposed | 2,461 | $1.43 |
| 4 Mar 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | S-Sale | Disposed | 756 | $1.43 |
| 4 Mar 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | S-Sale | Disposed | 4,198 | $1.43 |